Patient and clinician preferences for biologic treatments for severe uncontrolled asthma: a discrete choice experiment (DCE).
Melissa M RossYen ChungTara CarrChristopher S AmbroseAndrew W LindsleyHannah CollacottAndrea SchulzPooja DesaiPallavi RaneMatthew WilliamsHeather L GelhornPublished in: The Journal of asthma : official journal of the Association for the Care of Asthma (2024)
Asthma treatment preferences are largely driven by treatment efficacy and minimizing the risk of site reactions, although preferences differ between patients and clinicians across other attributes, highlighting the need for shared decision-making and individualized care.
Keyphrases
- end stage renal disease
- chronic obstructive pulmonary disease
- palliative care
- healthcare
- chronic kidney disease
- lung function
- rheumatoid arthritis
- ejection fraction
- newly diagnosed
- early onset
- peritoneal dialysis
- magnetic resonance
- computed tomography
- air pollution
- cystic fibrosis
- patient reported
- contrast enhanced